Literature DB >> 11168600

The role of anger and depression in recurrent headache.

V L Venable1, C R Carlson, J Wilson.   

Abstract

Individuals with tension-type headache report significant anger, depression, anxiety, and stressors. However, it is not clear to what extent these variables are interrelated. The objective of the present study was to explore the role of anger in headaches, and to examine its relationship to anxiety, depression, and daily life stressors. Participants were 65 young adult women who suffered from recurrent headaches. The sample was obtained in a large-scale screening of young adult women using the Headache Symptoms List to identify those with recurrent headache. Those individuals reporting headaches completed a battery of assessment measures that included the State-Trait Anger Expression Inventory, the Mood and Anxiety Symptoms Questionnaire, and the Hassles Scale. Results revealed a significant relationship between anger suppression and depression (r = 0.40, P<.01), as well as anger expression and anxiety (r = 0.41, P<.01) for those with headache. The use of the Mood and Anxiety Symptoms Questionnaire allowed for the separate analysis of general distress symptoms and symptoms more specific to anxiety and depression. Results indicated that those with headache experience more general, nonspecific distress rather than symptoms indicative of anxiety and depression (P<.01). In addition, the mixed headache group scored high on both general (mean, 28.96) and specific measures of depression (mean, 65.76) and on anger suppression (mean, 20.12), suggesting that they might experience more psychological distress than those with tension-type headache. The present results indicate the need to distinguish the unique dimensions of anxiety and depression that should be assessed in the population with recurrent headache.

Entities:  

Mesh:

Year:  2001        PMID: 11168600     DOI: 10.1046/j.1526-4610.2001.111006021.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  17 in total

Review 1.  The relationship between anger and pain.

Authors:  Ephrem Fernandez
Journal:  Curr Pain Headache Rep       Date:  2005-04

Review 2.  Anger inhibition and pain: conceptualizations, evidence and new directions.

Authors:  John W Burns; Phillip J Quartana; Stephen Bruehl
Journal:  J Behav Med       Date:  2008-05-23

Review 3.  Anger expression and pain: an overview of findings and possible mechanisms.

Authors:  Stephen Bruehl; Ok Y Chung; John W Burns
Journal:  J Behav Med       Date:  2006-06-29

Review 4.  Psychological issues in the evaluation and treatment of tension-type headache.

Authors:  Noah L Rosen
Journal:  Curr Pain Headache Rep       Date:  2012-12

Review 5.  Psychological risk factors in headache.

Authors:  Robert A Nicholson; Timothy T Houle; Jamie L Rhudy; Peter J Norton
Journal:  Headache       Date:  2007-03       Impact factor: 5.887

6.  Effects of anger awareness and expression training versus relaxation training on headaches: a randomized trial.

Authors:  Olga Slavin-Spenny; Mark A Lumley; Elyse R Thakur; Dana C Nevedal; Alaa M Hijazi
Journal:  Ann Behav Med       Date:  2013-10

Review 7.  Psychosocial factors and central sensitivity syndromes.

Authors:  Leah M Adams; Dennis C Turk
Journal:  Curr Rheumatol Rev       Date:  2015

Review 8.  Pain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms.

Authors:  Stephen Bruehl; John W Burns; Ok Y Chung; Melissa Chont
Journal:  Neurosci Biobehav Rev       Date:  2008-12-25       Impact factor: 8.989

Review 9.  Psychological issues in the evaluation and treatment of tension-type headache.

Authors:  Noah L Rosen
Journal:  Curr Pain Headache Rep       Date:  2008-12

10.  Trait anger management style moderates effects of actual ("state") anger regulation on symptom-specific reactivity and recovery among chronic low back pain patients.

Authors:  John W Burns; Amanda Holly; Phillip Quartana; Brandy Wolff; Erika Gray; Stephen Bruehl
Journal:  Psychosom Med       Date:  2008-08-25       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.